Dow Today: Cisco Systems (CSCO) Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average ( ^DJI) is trading up 38 points (+0.3%) at 12,853 as of Tuesday, Nov 13, 2012, 1:35 p.m. ET. During this time, 395.2 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 589.5 million. The NYSE advances/declines ratio sits at 1,328 issues advancing vs. 1,638 declining with 112 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is Cisco Systems (Nasdaq: CSCO), which is lagging the broader Dow index with a two-cent decline (-0.1%) bringing the stock to $16.83. Volume for Cisco Systems currently sits at 29.6 million shares traded vs. an average daily trading volume of 39.3 million shares.

Cisco Systems has a market cap of $89.19 billion and is part of the technology sector and computer hardware industry. Shares are down 7% year to date as of Monday's close. The stock's dividend yield sits at 3.3%.

Cisco Systems, Inc. designs, manufactures, and sells Internet protocol (IP) based networking and other products related to the communications and information technology industries worldwide. The company has a P/E ratio of 11.3, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Cisco Systems as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and attractive valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.

null

More from Markets

Eli Lilly's Trulicity Benefits From Growth of Diabetes Drugs

Eli Lilly's Trulicity Benefits From Growth of Diabetes Drugs

Stocks Tumble as Trump Comments Lead to Worries Over China Trade Talks

Stocks Tumble as Trump Comments Lead to Worries Over China Trade Talks

Tiffany & Co. Sees a Strong Market in Asia

Tiffany & Co. Sees a Strong Market in Asia

Imagining the Stock Market in 10 Years

Imagining the Stock Market in 10 Years

Video: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific

Video: Jim Cramer on the Markets, Tiffany, Micron Technology and Union Pacific